Taiwan Bio-Manufacturing Corporation (TBMC), a CDMO focused on advanced therapeutics, is currently building a GMP-compliant manufacturing facility in the Hsinchu Biomedical Science Park.

TBMC CEO David Chang was interviewed by The Chemical Daily on the company’s future growth strategy.